IL90056A - Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives - Google Patents

Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives

Info

Publication number
IL90056A
IL90056A IL90056A IL9005689A IL90056A IL 90056 A IL90056 A IL 90056A IL 90056 A IL90056 A IL 90056A IL 9005689 A IL9005689 A IL 9005689A IL 90056 A IL90056 A IL 90056A
Authority
IL
Israel
Prior art keywords
carboxylic acid
pharmaceutical compositions
compositions containing
acid derivatives
topical pharmaceutical
Prior art date
Application number
IL90056A
Other languages
English (en)
Other versions
IL90056A0 (en
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL90056A0 publication Critical patent/IL90056A0/xx
Publication of IL90056A publication Critical patent/IL90056A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL90056A 1988-04-26 1989-04-24 Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives IL90056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/186,242 US4861783A (en) 1988-04-26 1988-04-26 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases

Publications (2)

Publication Number Publication Date
IL90056A0 IL90056A0 (en) 1989-12-15
IL90056A true IL90056A (en) 1993-04-04

Family

ID=22684175

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90056A IL90056A (en) 1988-04-26 1989-04-24 Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives

Country Status (16)

Country Link
US (1) US4861783A (xx)
EP (1) EP0339484B1 (xx)
JP (1) JP2650756B2 (xx)
KR (1) KR0124817B1 (xx)
AT (1) ATE84716T1 (xx)
AU (1) AU610469B2 (xx)
CA (1) CA1336263C (xx)
DE (1) DE68904462T2 (xx)
DK (1) DK199789A (xx)
ES (1) ES2053856T3 (xx)
IE (1) IE64285B1 (xx)
IL (1) IL90056A (xx)
MY (1) MY104006A (xx)
NZ (1) NZ228894A (xx)
PT (1) PT90362B (xx)
ZA (1) ZA893086B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5281196A (en) * 1992-05-22 1994-01-25 Sultenfuss Thomas J Skin treatment composition and method of use
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
KR20010014030A (ko) 1997-06-19 2001-02-26 더글라스이.리디치 퀴놀린-인돌 항균제, 이들의 용도 및 조성물
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
JP4318087B2 (ja) * 2004-12-13 2009-08-19 小野薬品工業株式会社 アミノカルボン酸誘導体およびその医薬用途
CA2925546C (en) 2012-10-29 2022-06-14 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
AU2014352920A1 (en) 2013-11-22 2016-06-23 Genzyme Corporation Novel methods for treating neurodegenerative diseases
MX2019005751A (es) 2016-11-17 2019-11-12 Renovion Inc Tratamiento de enfermedades e infecciones de las vias respiratorias con composiciones de acido ascorbico.
AU2018367674A1 (en) 2017-11-17 2020-06-04 Renovion, Inc. Stable ascorbic acid compositions and methods of using the same
MX2024008001A (es) 2022-01-04 2024-07-12 Renovion Inc Solucion acuosa que comprende una sal de glutation.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
CA1288436C (en) * 1983-07-22 1991-09-03 David Paul Hesson Phenylquinolinecarboxylic acids and derivatives as antitumor agents
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids

Also Published As

Publication number Publication date
DE68904462D1 (de) 1993-03-04
DK199789A (da) 1989-10-27
US4861783A (en) 1989-08-29
EP0339484A1 (en) 1989-11-02
JP2650756B2 (ja) 1997-09-03
KR900016135A (ko) 1990-11-12
IE891329L (en) 1989-10-26
IL90056A0 (en) 1989-12-15
DE68904462T2 (de) 1993-05-13
JPH0272163A (ja) 1990-03-12
DK199789D0 (da) 1989-04-25
NZ228894A (en) 1992-02-25
CA1336263C (en) 1995-07-11
ES2053856T3 (es) 1994-08-01
ZA893086B (en) 1990-12-28
EP0339484B1 (en) 1993-01-20
AU610469B2 (en) 1991-05-16
MY104006A (en) 1993-10-30
KR0124817B1 (ko) 1997-11-25
PT90362B (pt) 1994-07-29
AU3331889A (en) 1989-11-02
PT90362A (pt) 1989-11-10
IE64285B1 (en) 1995-07-26
ATE84716T1 (de) 1993-02-15

Similar Documents

Publication Publication Date Title
AU1331588A (en) Method for treatment of alcohol abuse
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
MD921G2 (ro) Derivaţi arilpropionici, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
RU92016445A (ru) Применение амидов изоксазол-4-карбоновой кислоты и амидов гидроксиалкилиденциануксусной кислоты
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
ZA884919B (en) 3-demethylmevalonic acid derivatives,a process for their preparation,pharmaceutical products based on these compounds,their use and intermediates
HK83888A (en) Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids,novel carboxylic acid salts and the production thereof
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
ZA895959B (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof,the use thereof as medicinal agents,pharmaceutical products and intermediates
IL109151A0 (en) Pharmaceutical preparations for the treatment of skin disorders
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
AU532982B2 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2- carboxylic acid esters
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
IT1197289B (it) Sale di lisina dell'acido 4-bifenilacetico e sue composizioni oftalmiche
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
AU3471589A (en) Novel 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiophenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, processes for the preparation of these compounds their use as pharmaceuticals
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
HU904860D0 (en) Process for the production of medical preparations containing isoflavonic derivatives or salts thereof as active agents
AU1753188A (en) Treating agents for renal diseases
EG19465A (en) Process for the production of basically substituted benzylphthalazone derivatives and acid addition salts thereof.
HU9201483D0 (en) Process for the production of 1h-rh-analogues'acid additive salts, and for the production of medical preparations containing them
IT8421275A0 (it) Derivato dell'acido 2-(3-benzoil-fenil)propionico, procedimento per la sua preparazione e forme farmaceutiche contenenti lo stesso.

Legal Events

Date Code Title Description
RH Patent void